News

The medical device has been developed under Department of Biotechnology (DBT), Ministry of Science & Technology supported Bio design Programme by Consure Medical, New Delhi. 

 

Med-Tech innovation Program of DBT, a spin-off of the Bio design Programme, is implemented at AIIMS and IIT, Delhi in collaboration with International partners such as Stanford University, USA, Queensland University of Technology, Australia and Tottori University and Japan. 

 

Fecal incontinence (FI) is a medical condition marked by inability to control one’s bowel movements, causing stool (feces) to leak unexpectedly from the rectum. It affects nearly 100 million bed ridden patients worldwide. Furthermore, about 50% of the psychiatric ward patients have FI due to long-term neurological diseases. Absorbent pads and fecal drainage catheters are the only available solutions for this condition a need for a better solution was felt by the team. 

 

Nishith Chasmawala and Amit Sharma, founders of Consure Medical, are the inventors of the technology. 

 

The product was clinically validated at AIIMS, New Delhi. 

 

Consure Medical has developed the QoraTM Stool Management Kit, the world’s first FDA 510(k) approved indwelling fecal drainage device for the management of fecal incontinence that can be used across a continuum of care facilities from ICUs to nursing homes. 

 

The intellectual property for the company’s core QoraTM technology under DBT’s ownership has been granted in key markets, including US, EU, Canada, Singapore, Australia, and Japan.